News

Injectable medications for obesity found to produce smaller weight loss in a real-world setting
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...
News-Medical.Net on MSN6d
Real-world study finds lower weight loss with GLP-1 drugs due to early discontinuation
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...
Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...
You need more than Ozempic to fight food addiction. Here's how
GLP-1 weight loss drugs, such as Wegovy and Zepbound, have helped millions of people shed weight and curb food cravings. But they create additional health problems, Kessler says, and there's not ...
Zacks.com on MSN5d
NVO Stock Gains After Parvus Asset Management Builds Stake
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Lilly to offer highest doses of weight-loss drug Zepbound on website
U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...
Lilly will offer higher doses of Zepbound on its website
Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
foxbangor.com5d
Real-World Results For GLP-1 Drugs Underwhelm, Study Says
WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...